News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Liyi Cen

Articles by Liyi Cen

28 Pooled Analysis of Post- Progression Treatments After Firstline Ribociclib + Endocrine Therapy in Patients With HR+/HER2− Advanced Breast Cancer in the MONALEESA-2, -3, and -7 Studies

ByKevin Kalinsky, MD, MS,Erika P. Hamilton, MD,Laura Spring,Peter A. Fasching,Sandra Franco, MD,Richard De Boer,Javier Cortes,Dejan Juric,Aditya Bardia, MD, MPH, FASCO,Sina Haftchenary,Agnes Lteif,Juan Pablo Zarate,Liyi Cen,Patrick Neven, MD, PhD

April 27th 2023

Latest Updated Articles

Trending on CancerNetwork

EMA’s Review of Daraxonrasib in PDAC Accelerated Under Phased Review Process

Orca-T Improves Chronic GVHD-Free Survival in Hematologic Cancers

Risvutatug Rezetecan Improves Overall Survival in Relapsed SCLC Trial

FDA OKs Pembrolizumab/EV Combo in Muscle Invasive Bladder Cancer

TIP12 Validation of a Multimodal Artificial Intelligence Prognostic Model in Early-Stage HR+/HER2− Breast Cancer